Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid

• References

• 1 Carreras LO. Thrombosis and thrombocytopenia induced by heparin. Scand J Haematol 1980; (Suppl. 36) 64-80
• 2 Cines DB, Kaywin P, Bina M, Tomaski H, Schrieber AD. Heparin-associated thrombocytopenia. N Engl J Med 1980; 303: 788-795
• 3 Van der Meer J, Stoepman-van Dalen EA, Jansen J MS. Antithrombin III deficiency in a Dutch family. J Clin Path 1973; 26: 532-538
• 4 Ten Cate H, Lamping RJ, Henny ChP, Prins A, ten Cate JW. Automated amidolytic method for determining heparin, a heparinoid, and a low-MW heparin fragment, based on their anti-Xa activity. Clin Chem 1984; 30: 860-864
• 5 Meuleman DG, Hobbelen P MJ, van Dedem G, Moelker H CT. A novel antithrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models. Thromb Res 1982; 27: 353-363
• 6 Ten Cate H, Henny ChP, Mooy MC, ten Cate JW, Surachno S, Wilmink JM. The anticoagulant and antithrombotic effects of a low molecular weight heparinoid Org 10172 in human volunteers and haemodialysis patients. Thromb Res 1985; 39: 211-223
• 7 Ten Cate H, Henny ChP, Büller HR, ten Cate JW, Magnani HW. Use of a heparinoid in hemorrhagic stroke patients with thromboembolic disease. Ann Neurol 1984; 15: 268-270
• 8 Mikhalaides BP, Barradas MA, Mikhaliades AM, Magnani HN, Dandona P. Comparison of a conventional heparin and a low molecular weight heparinoid on platelet function. Br J Clin Pharmacol 1984; 17: 43-48